...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: No news
1
Sep 15, 2022 10:50AM
3
Sep 15, 2022 12:38PM
8
Sep 15, 2022 02:07PM
5
Sep 16, 2022 09:42AM
6
Sep 16, 2022 11:16AM
2
Sep 16, 2022 11:43AM
3
Sep 16, 2022 12:09PM
6
ARR
Sep 16, 2022 01:01PM
3
Sep 16, 2022 03:22PM
6
ARR
Sep 16, 2022 03:56PM
6
Sep 16, 2022 04:29PM
6
Sep 16, 2022 05:16PM
8
Sep 17, 2022 12:12AM
2
Sep 17, 2022 06:19AM
6
Sep 17, 2022 08:12AM
3
Sep 17, 2022 09:14AM
4
Sep 17, 2022 09:47AM
4
Sep 17, 2022 11:08AM
5
Sep 17, 2022 11:13AM
5
Sep 17, 2022 11:56AM
8
Sep 17, 2022 02:49PM

tada, here is the recap of Zenith's ZEN-3694-Combination, Clinical Trials:

https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/bet-bromodomain-inhibitor-zen-3694

 

Koo

4
Sep 18, 2022 03:17PM
2
Sep 19, 2022 11:35AM
3
Sep 19, 2022 04:23PM
3
Sep 20, 2022 02:03PM
Share
New Message
Please login to post a reply